# Stonehenge Capital

> Stonehenge Capital is a VC fund in Stamford backing Health Care and Software. See 45 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Stamford, United States
- Total investments: 45
- Last investment: Jul 2026
- Lead investor: 18%
- Fund size: $3.5M
- Last fund: Sep 2020
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/stonehenge-capital/
- X (Twitter): https://twitter.com/stonehengecaptl
- Website: http://www.stonehengecapital.com

Stonehenge Capital is a national specialty finance company, with expertise in private equity, tax credit, and structured finance.Since 1990, Stonehenge's principals have provided long-term capital to privately held businesses throughout the country. Stonehenge was formed in 1999 by former principals of Banc One Capital Markets, the venturecapital and investment banking subsidiary of Bank One Corporation.Stonehenge currently manages several distinct private equity and mezzanine investment funds with over $500 million in capital through its offices in Alabama, Colorado, Florida, Louisiana, Missouri, New York, Ohio, Texas, and Wisconsin.

## Contacts

5 contacts available for Stonehenge Capital. Shizune tracks 8 team members at Stonehenge Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/stonehenge-capital?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 10 | 22% |
| Software | 8 | 18% |
| Biotechnology | 6 | 13% |
| Manufacturing | 5 | 11% |
| Information Technology | 5 | 11% |

71 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 14 | 31% |
| Funding Round | 12 | 27% |
| Series B | 10 | 22% |
| Series C | 2 | 4% |
| Seed | 1 | 2% |

8 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 35 | 78% |
| Spain | 1 | 2% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Anna Kathryn Barber | Director | 0 | https://shizune.co/investors/profile/anna-kathryn-barber |
| Gordon S. LeBlanc, Jr. | Managing Director | 0 | https://shizune.co/investors/profile/gordon-s-leblanc-jr |
| John P. Witten | Managing Director | 0 | https://shizune.co/investors/profile/john-p-witten |
| Jonathan M. Crawford | Director | 0 | https://shizune.co/investors/profile/jonathan-m-crawford |
| L'Quentus Thomas | Managing Director | 0 | https://shizune.co/investors/profile/lquentus-thomas |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Heelstone Renewable Energy | Heelstone founded in 2012 and since that time it has experienced steady growth and solidified itself as a leader in the industry. Its founders leveraged their extensive structured finance expertise to acquire early and mid-stage development projects in solar markets across the country. As Heelstone continued to grow and evolve, it was able toorganically develop an expertise spanning all components of the downstream solar value chain; that is, greenfield development, mid-stage development, finance, construction, and operation. In 2019, Heelstone received an investment from funds managed by Ares Management Corporation’s (NYSE: ARES) Infrastructure and Power Group (AIPG). With that investment and the deep industry expertise and support from the AIPG team, Heelstone will continue to expand its development capabilities and reach as a utility-scale solar developer. |  |  | Jul 20, 2026 |  |
| Zelestra | Zelestra is a renewable energy company dedicated to serving clients through customized solutions, local employment, and strong sustainability. | $60M |  | Oct 30, 2025 |  |
| Wellinks | Wellinks (previously Convexity Scientific) is a New Haven Connecticut based digital health company focused on innovations to reinvent respiratory care around the people who need it. The company began as Convexity Scientific, launching a FDA cleared portable nebulizer, Flyp, to the market in 2018. In transforming to Wellinks, Convexity Scientificacquired an early stage startup in the connected medical device and digital health field. Merging the teams and moving forward under the Wellinks brand, the combined company has created a digital health solution for chronic respiratory disease management that incorporates a suite of connected medical devices and software to enable optimized medication adherence, symptom tracking, diagnostic monitoring, and personalized coaching. | $25M | Series C | Nov 03, 2021 |  |
| Wellinks (formerly Convexity Scientific) | Wellinks is a COPD disease management organization that provides clients with individualized treatment and assistance to help them manage their condition successfully. They focus on each member's individual needs to create a clear route to better health. | $25M | Series C | Nov 03, 2021 |  |
| Lilyana Naturals | Lilyana Naturals is a cosmetic manufacturing company that offers facial moisturizers, eye creams, masks, and cleanser products. |  | Venture - Series Unknown | Aug 13, 2020 |  |
| Flyp Nebulizer | Flyp Nebulizer, the medical device is reinvented by Weblinks for respiratory care around the people who need it most. It works at ultrasonic speed to create a fine aerosol of medication. Flyp Nebulizer works quickly to deliver treatment within 7-minute average. | $4M | Series B | Sep 27, 2019 |  |
| Wellinks | Wellinks (previously Convexity Scientific) is a New Haven Connecticut based digital health company focused on innovations to reinvent respiratory care around the people who need it. The company began as Convexity Scientific, launching a FDA cleared portable nebulizer, Flyp, to the market in 2018. In transforming to Wellinks, Convexity Scientificacquired an early stage startup in the connected medical device and digital health field. Merging the teams and moving forward under the Wellinks brand, the combined company has created a digital health solution for chronic respiratory disease management that incorporates a suite of connected medical devices and software to enable optimized medication adherence, symptom tracking, diagnostic monitoring, and personalized coaching. | $14M | Series B | Sep 26, 2019 |  |
| Atlantic Beverage Company | Atlantic Beverage Company is a national food service supplier company. |  | Private Equity | Aug 16, 2018 |  |
| SmartPay Solutions | SmartPay™: The leading cloud-based solution provider of workers' comp pay-go systems to insurance carriers, independent agents & payroll providers. - Leading edge technology - Virtual software platform - Plug & play – immediate access - Designed to meet everyone's needs | $2.1M | Series A | Aug 05, 2016 |  |
| SmartPay Solutions | SmartPay™: The leading cloud-based solution provider of workers' comp pay-go systems to insurance carriers, independent agents & payroll providers. - Leading edge technology - Virtual software platform - Plug & play – immediate access - Designed to meet everyone's needs | $1.4M | Series A | Jun 03, 2014 |  |

10 of 45 investments shown.

## Co-investors
- [Silicon Alley Venture Partners](https://shizune.co/investors/profile/silicon-alley-venture-partners) — VC Fund, 8 deals together
- [Connecticut Innovations](https://shizune.co/investors/profile/connecticut-innovations) — VC Fund, 7 deals together
- [Advantage Capital](https://shizune.co/investors/profile/advantage-capital-partners) — VC Fund, 5 deals together
- [Benslie Investment Group](https://shizune.co/investors/profile/benslie-international-ltd) — VC Fund, 4 deals together
- [HighCape Partners](https://shizune.co/investors/profile/highcape-partners) — VC Fund, 4 deals together
- [Himalaya Capital Ventures](https://shizune.co/investors/profile/himalaya-capital-ventures) — VC Fund, 3 deals together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Stonehenge Capital invest in?

Stonehenge Capital invests primarily in Health Care, Software and Biotechnology startups, most often at Series A and Funding Round stage. Most of the 45 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Stonehenge Capital?

Public channels for Stonehenge Capital include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Stonehenge Capital?

The team at Stonehenge Capital includes Anna Kathryn Barber (Director), Gordon S. LeBlanc, Jr. (Managing Director) and John P. Witten (Managing Director), among 8 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co